source
- Fujifilm Biotech CEO warns CDMOs must expand services ahead of looming patent cliffFujifilm Biotechnologies CEO Lars Petersen said drugmakers are gearing up for a looming biopharma patent cliff in 2026, a situation that could pressure revenue streams as key patents expire. He wa…
- FDA questions efficacy of Capricor's Duchenne muscular dystrophy cell therapy ahead of advisory committeeFDA reviewers have raised concerns about the efficacy of Capricor's cell therapy for Duchenne muscular dystrophy as the agency prepares for an advisory committee meeting. The agency said it could n…